Tarrier N, Kinney C, McCarthy E, Humphreys L, Wittkowski A, Morris J
Academic Division of Clinical Psychology, University of Manchester, United Kingdom.
J Consult Clin Psychol. 2000 Oct;68(5):917-22.
The article reports the 2-year follow-up of patients suffering persistent symptoms of schizophrenia who entered a single blind randomized controlled trial. Patients were randomly allocated to cognitive-behavioral therapy (CBT) plus routine care (RC), supportive counseling (SC) plus RC, or RC alone. Treatment took place over 3 months, and follow-up was made 12 and 24 months after treatment finished. Sixty-one patients were available to the 2-year follow-up and assessed for positive and negative symptoms and clinical improvement; all of the 87 patients who entered the trial were assessed for relapse over the follow-up period. On all measures, patients who received RC alone did significantly worse at 2 years. There were no significant differences at 2 years between the CBT and SC groups.
本文报道了进入一项单盲随机对照试验的持续性精神分裂症症状患者的2年随访情况。患者被随机分配至认知行为疗法(CBT)加常规护理(RC)组、支持性咨询(SC)加RC组或仅RC组。治疗为期3个月,治疗结束后12个月和24个月进行随访。61名患者接受了2年随访,并对阳性和阴性症状及临床改善情况进行了评估;对进入试验的所有87名患者在随访期内的复发情况进行了评估。在所有指标上,仅接受RC组的患者在2年时情况明显更差。CBT组和SC组在2年时无显著差异。